Acantholytic herpetiform dermatitis.
D000051:Acantholysis / Q000150:complications / Q000473:pathology; D000906:Antibodies / Q000032:analysis; D000974:Antibodies, Antinuclear / Q000032:analysis; D001706:Biopsy; D001768:Blister / Q000473:pathology; D003622:Dapsone / Q000008:administration & dosage / Q000627:therapeutic use; D003874:Dermatitis Herpetiformis / Q000145:classification / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007074:Immunoglobulin G / Q000032:analysis; D008854:Microscopy, Electron; D008875:Middle Aged; D010392:Pemphigus / Q000276:immunology / Q000473:pathology*; D012008:Recurrence; D012867:Skin / Q000473:pathology*; D012882:Skin Tests
D000906:Antibodies; D000974:Antibodies, Antinuclear; D007074:Immunoglobulin G; D003622:Dapsone